WASHINGTON — National Institutes of Health Director Jay Bhattacharya plans to name John Powers, the interim leader of the National Institute of Allergy and Infectious Diseases, as the agency’s permanent director Monday, signaling a shift away from biodefense work and toward fundamental immunology.
Powers, a 20-year NIAID veteran, will become the institute’s fourth director in four years. Bhattacharya said the appointment would mark a new chapter for the agency and bring an end to what he described bluntly as the “mad science experiments” associated with former director Anthony Fauci.
Fauci led NIAID for four decades, overseeing major advances in lifesaving HIV treatments. During his tenure, biodefense and emerging-infection research also expanded to consume the largest share of the institute’s annual budget.
“There’s a strict adherence to the work to make sure that it doesn’t — we don’t — conduct, you know, just bluntly, mad science experiments,” Bhattacharya told The Post in an interview Friday. “No more dangerous gain of function will happen under John’s leadership.”
Public scrutiny of taxpayer-funded biodefense research intensified during the COVID-19 pandemic, prompting heated congressional disputes between Fauci and lawmakers over whether such work may have played a role in the emergence of the virus that causes SARS-CoV-2.
In fiscal year 2025, about one-third of NIAID’s budget — more than $2.2 billion — was directed to biodefense programs. Those programs will now be overseen by the Department of War.
“We’re now purely a civilian agency,” Bhattacharya said. “We’re moving to shift the portfolio so it’s more balanced toward infectious diseases that Americans actually get.”
Powers said his priorities were shaped by his early clinical experience treating HIV patients. “I was there when HIV patients were dying,” he said. “And we made tremendous progress in that area. But right now we’re able to send HIV patients home with one pill once a day.” He said the institute would place greater emphasis on implementation research aimed at delivering effective interventions to people who need them.
Bhattacharya and Powers said they had reviewed more than 8,000 research grants to confirm that none involved dangerous laboratory experiments that would fall under biodefense.
Bhattacharya characterized biodefense research as efforts to locate emerging diseases in remote areas, bring them into laboratories, increase their transmissibility or ability to infect humans, and develop largely hypothetical and insufficiently tested countermeasures. “We’re out of that business altogether,” he said.
“There were civilian justifications, but those justifications were far-fetched, right?” Bhattacharya added. “The idea that we could prepare for all pathogens out there — they’re literally in the trillions — and somehow develop countermeasures for all the most important ones by making them more pathogenic.”
Fauci has repeatedly told Congress that his agency never funded such experiments at the Wuhan Institute of Virology, located in the city where COVID-19 was first identified in late 2019. Bhattacharya and other scientists have challenged that account or said it is impossible to determine what Chinese researchers conducted under the US-funded grant.
As the public face of the US response to COVID-19, Fauci also criticized his opponents for undermining trust in science, saying, “because I represent science.” However, entries from his private diary showed him expressing uncertainty about theories that the virus arose through natural spillover.
Congressional investigations also uncovered emails indicating that Fauci maintained a “secret back channel” with senior adviser David Morens while Morens sought to have funding for research at the Wuhan institute restored.
During congressional testimony in June 2024, Fauci distanced himself from Morens, saying he “knew nothing” about the alleged use of a private Gmail account to discuss official grants, including purported kickbacks. He also said Morens was not his adviser.
Morens later pleaded guilty in August to charges involving the concealment of federal records related to the grants, which are considered important to investigations into COVID-19’s origins. The previous month, Fauci invoked the Fifth Amendment more than 100 times during congressional testimony to avoid answering questions.
“What happened in the pandemic … didn’t feel like science to me,” Bhattacharya said, arguing that Fauci’s conduct was “at the root of a lot of the distrust that Americans have over the NIH.”
“It felt like a perversion of science that focused more on power, rather than on truth,” he added.
Bhattacharya also criticized the extensive redactions NIH officials made to records requested by journalists, scientists and members of the public.
“We’ve been working closely with Congress in delivering a whole bunch of records from that era,” he said.
Powers said the new direction at NIAID would also distance the institute from “setting policy,” another source of controversy during the pandemic.
“As a practicing physician, I think there’s still some outstanding questions that remain to be addressed about things like masks,” he said. “Our job is to actually help support the research that would answer those questions.”
“But our job is not to tell everybody what to do,” Powers added. “Our job is to provide them with the information to make the best decisions.”